← Back to Search

Robotic Surgery

Extraperitoneal SinglePort (SP) Robotic Radical Prostatectomy (Da Vinci ® SP system) for Prostate Cancer

N/A

Waitlist Available

Led By Jihad Kaouk, MD

Research Sponsored by Case Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

Study Summary

This trial is comparing two different ways to do a surgery that is already the standard of care for treating prostate cancer. The study is looking to see if one method of surgery, which uses a single incision, results in a better recovery than the method that uses six small incisions.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Recovery of Urinary Continence Following Catheter Removal

Secondary outcome measures

Body image questionnaire scores

Estimated blood loss in milliliters

Hospital stay in hours

+16 more

Trial Design

2Treatment groups

Active Control

Group I: Extraperitoneal SinglePort (SP) Robotic Radical Prostatectomy (Da Vinci ® SP system)Active Control1 Intervention

All participants will undergo SOC robotic radical prostatectomy. The procedure for this arm uses the Da Vinci ® SP system. Access point consists of one 3.5 cm single infraumbilical incision for the SP-RARP

Group II: Extraperitoneal MultiPort (MP) Robotic Radical Prostatectomy (Da Vinci ® Xi system)Active Control1 Intervention

All participants will undergo SOC robotic radical prostatectomy. The procedure for this arm uses the Da Vinci ® Xi system, where four 8mm trocars will be used along with a 12 mm assistant trocar (a surgical instrument) to create six small incisions during the surgery

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor

452 Previous Clinical Trials

31,844 Total Patients Enrolled

31 Trials studying Prostate Cancer

3,047 Patients Enrolled for Prostate Cancer

Jihad Kaouk, MDPrincipal InvestigatorCleveland Clinic, Case Comprehensive Cancer Center

2 Previous Clinical Trials

295 Total Patients Enrolled

1 Trials studying Prostate Cancer

276 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you provide a figure of the individuals participating in this research project?

"Affirmative. According to information posted on clinicaltrials.gov, this medical study is presently recruiting participants; the listing was first published on September 1st 2022 and most recently updated November 8th 2022. Sixty-six patients are needed from one primary site for participation in the trial."

Answered by AI

Are there still openings available for people to join this research effort?

"Affirmative. Evidenced from the data on clinicaltrials.gov, this medical trial is presently in search of 66 individuals to enrol at a single site. The first post was made on September 1st 2022 and it was last updated November 8th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Single-Port Versus Multi-Port Robotic Radical Prostatectomy

2022. "Single-Port Versus Multi-Port Robotic Radical Prostatectomy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04696263.